New Day Diagnostics Logo
  • Home
  • ColoHealth
    • Patient Information
    • Physician Information
  • CLIA Laboratory
  • Products
    • Colorectal Cancer
    • AxSpA
      • Patient Information
      • Physician Information
    • Celiac
    • H. pylori
    • Covid-Flu-RSV
    • COVID-19
    • Oncology Product Pipeline
      • ColoPlex Plus
      • Procare
  • About Us
    • Our Team
    • News
    • For Media

EDP Biotech now able to be an antibody testing resource for local employers

by Jessica Etheridge | Jul 16, 2020 | News and Events, Products & Pipeline

EDP Biotech is able to be a testing resource for local employers, thanks to the local company’s designation as a CLIA-certified lab. CLIA stands for the Clinical Laboratory Improvement Amendments of 1988 that established federal regulatory standards applicable to all...

COVID-19 Antibody Testing In Tennessee

by Jessica Etheridge | Jun 1, 2020 | News and Events, Products & Pipeline

EDP Biotech Corporation is a local small business whose mission is to develop and commercialize cost-effective blood tests to detect disease early.  We operate a CLIA Certified laboratory (CLIA 44D2184836) and an ISO Certified Bio-Safety Level II facility right here...

Knoxville firm EDP Biotech is working overtime to develop a COVID-19 antibody test

by Jessica Etheridge | May 5, 2020 | News and Events, Products & Pipeline

Knoxville News Sentinel – A small Knoxville firm that manufactures early detection tests for colon cancer has switched gears to quickly develop a COVID-19 antibody test. EDP Biotech CEO Eric Mayer told Knox News the company is pursuing certifications to sell and...

EDP Biotech FDA Notification and Listing for COVID-19 Serology (antibody) Testing

by Jessica Etheridge | Apr 15, 2020 | News and Events, Products & Pipeline

EDP Biotech has recently notified the US FDA, and received a listing on the FDA.gov FAQ website, related to its plans to perform COVID-19 serology (antibody) testing in the state of Tennessee.  EDP Biotech’s mission has always been to develop and commercialize cost...

Dr. Anna podcast on Colorectal Cancer featuring EDP Biotech

by Jessica Etheridge | Dec 3, 2019 | News and Events, Products & Pipeline

Doctor Anna talks colorectal cancer with Eric Mayer and Jason Liggett, Ph.D from EDP biotech, a company that is focused on early detection methods for this devastating disease. Listen on YouTube!

EDP Biotech partners with 2nd Generation Capital (Nashville investment banking) to complete $5M Series A Round

by Jessica Etheridge | Oct 3, 2019 | News and Events, Products & Pipeline

10/20/2019 – EDP Biotech Corporation has recently partnered with 2nd Generation Capital for their advisory and investment banking services (d/b/a of BrightChoice Financial, LLC, FINRA CRD#147509), member FINRA & SIPC. 2ndG has been the lead adviser for debt &...
« Older Entries
Next Entries »

Topics

  • Articles
  • Company Details
  • News and Events
  • Products & Pipeline
  • Research & Development
  • Uncategorized

Recent Posts

  • Press Release: ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening–Now Direct-to-Consumer
  • Hepion Pharmaceuticals, New Day Diagnostics execute binding letter of intent
  • Press Release: Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC
  • We’ve Been Busy, and the Press Has Noticed!
  • Knoxville lab launches blood test for colorectal cancer screening across US: ‘Life mission’

New Day Diagnostics Home

ColoHealth Home

Call Us: 865-299-6250
Email Us: [email protected]

Legal

Privacy

E-Library

BSI Medical Device Quality Assurance Mark
clia logo

CLIA#: 44D2184836

  • Follow
  • Follow
Knoxville Chamber of Commerce Member

Copyright © 2012-2024. All Rights Reserved.
Web Site usage is subject to New Day Diagnostics / EDP Biotech’s Web Site Usage and Privacy Policy. Copyright ©2024 New Day Diagnostics, All Rights Reserved. All other copyrights are owned by their respective owners.